Developing novel pain management therapies based on known chemical entities.
Industry: Health Care
First Day Return: -6.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 02/07/2007 |
Offer Price | $11.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $44 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/01/2007 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $44 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Carlos, CA, United States |
Founded | 1998 |
Employees at IPO | n/a |
Website www.neurogesx.com |